Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Livongo Health, Inc. (LVGO) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/09/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
11/03/2020 SC 13D/A GC Venture LH Manager, LLC reports a 0% stake in Livongo Health, Inc.
11/03/2020 SC 13D/A Kinnevik AB reports a 0% stake in Livongo Health, Inc.
10/30/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/30/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/30/2020 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/30/2020 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp...
Docs: "AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF LIVONGO HEALTH, INC. 1. Name . The name of the corporation is Livongo Health, Inc. . 2. Address; Registered Office and Agent . The name and address of the Corporation’ s registered agent is Corporation Service Company, 251 Little Falls Drive in the City of Wilmington, County of New Castle, Delaware, 19808. 3. Purpose . The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of the State of Delaware . 4. Number of Shares . The total number of shares of stock that the Corporation shall have authority to issue is 1,000, all of which shall be shares of Common Stock with the par value of $0.01 per share. 5. Election of Directors . Unless and except to ...",
"BYLAWS OF LIVONGO HEALTH, INC. ARTICLE I Meetings of Shareholders: Shareholders’ Consent in Lieu of Meeting Section 1.01. Annual Meeting . The annual meeting of the shareholders for the election of directors, and for the transaction of such other business as may properly come before the meeting, shall be held at such place, date and hour as shall be fixed by the Board of Directors and designated in the notice or waiver of notice thereof; except that no annual meeting need be held if all actions, including the election of directors, required by the General Corporation Law of the State of Delaware to be taken at a shareholders’ annual meeting are taken by written consent in lieu of meeting pursuant to Section 1.03 of this Article. Section 1.02. Special Meetings . A special meeting of the sha...",
"LIVONGO HEALTH, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of June 4, 2020 0.875% Convertible Senior Notes due 2025",
"FIRST SUPPLEMENTAL INDENTURE",
"This WAIVER, CONSENT AND FOURTH Amendment to Loan and Security Agreement is entered into this 30th day of October, 2020, by and between SILICON VALLEY BANK, a California corporation , and LIVONGO HEALTH, INC., a Delaware corporation (“Borrower"
10/30/2020 8-K Submission of Matters to a Vote of Security Holders, Other Events
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : October 29, 2020 Livongo Health, Inc. Delaware 001-38983 26-3542036 150 West Evelyn Avenue, Suite 150 Mountain View, California 94041 435-5643 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☒ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-..."
10/30/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/29/2020 GN Teladoc Health Announces Shareholder Approvals in Merger with Livongo
10/29/2020 8-K Other Events
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report : October 29, 2020 Livongo Health, Inc. Delaware 001-38983 26-3542036 150 West Evelyn Avenue, Suite 150 Mountain View, California 94041 435-5643 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☒ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-..."
10/29/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/28/2020 8-K Quarterly results
Docs: "Livongo Reports Third Quarter 2020 Financial Results"
10/28/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/28/2020 GN Livongo Reports Third Quarter 2020 Financial Results
10/27/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/23/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/22/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/21/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/21/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/16/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/16/2020 8-K Quarterly results
10/16/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/16/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/16/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/15/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/15/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/15/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/15/2020 GN Livongo to Release Results for the Third Quarter of Fiscal Year 2020
10/13/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/13/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/13/2020 425 Form 425 - Prospectuses and communications, business combinations:
10/09/2020 8-K Quarterly results
10/09/2020 425 Form 425 - Prospectuses and communications, business combinations:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy